Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA)

Rodríguez-Artalejo, Fernando; Guallar, Eliseo; Borghi, Claudio; Dallongeville, Jean; De Backer, Guy; Halcox, Julian P.; Hernández-Vecino, Ramón; Jiménez, Francisco Javier; Massó-González, Elvira L; Perk, Joep; Steg, Philippe Gabriel; Banegas, José R.; Rodríguez-Artalejo, Fernando; Hernández-Vecino, Ramón; Jiménez, Francisco Javier; Massó-González, Elvira L; Banegas, José R; EURIKA Investigators
January 2010
BMC Public Health;2010, Vol. 10 Issue 1, p382
Academic Journal
journal article
Background: The EURIKA study aims to assess the status of primary prevention of cardiovascular disease (CVD) across Europe. Specifically, it will determine the degree of control of cardiovascular risk factors in current clinical practice in relation to the European guidelines on cardiovascular prevention. It will also assess physicians' knowledge and attitudes about CVD prevention as well as the barriers impeding effective risk factor management in clinical practice.Methods/design: Cross-sectional study conducted simultaneously in 12 countries across Europe. The study has two components: firstly at the physician level, assessing eight hundred and nine primary care and specialist physicians with a daily practice in CVD prevention. A physician specific questionnaire captures information regarding physician demographics, practice settings, cardiovascular prevention beliefs and management. Secondly at the patient level, including 7641 patients aged 50 years or older, free of clinical CVD and with at least one classical risk factor, enrolled by the participating physicians. A patient-specific questionnaire captures information from clinical records and patient interview regarding sociodemographic data, CVD risk factors, and current medications. Finally, each patient provides a fasting blood sample, which is sent to a central laboratory for measuring serum lipids, apolipoproteins, hemoglobin-A1c, and inflammatory biomarkers.Discussion: Primary prevention of CVD is an extremely important clinical issue, with preventable circulatory diseases remaining the leading cause of major disease burden. The EURIKA study will provide key information to assess effectiveness of and attitudes toward primary prevention of CVD in Europe. A transnational study creates opportunities for benchmarking good clinical practice across countries and improving outcomes. (ClinicalTrials.gov number, NCT00882336).


Related Articles

  • The autumn brings the fruits. Avdic, Dijana // Journal of Health Sciences;Sep2012, Vol. 2 Issue 2, p99 

    An introduction is presented in which the editor discusses various reports within the issue on topics including lipid status in post-menopausal women, cardiovascular diseases and tumor biomarkers.

  • Sleep and Multisystem Biological Risk: A Population-Based Study. Carroll, Judith E.; Irwin, Michael R.; Merkin, Sharon Stein; Seeman, Teresa E. // PLoS ONE;Feb2015, Vol. 10 Issue 2, p1 

    Background: Short sleep and poor sleep quality are associated with risk of cardiovascular disease, diabetes, cancer, and mortality. This study examines the contribution of sleep duration and sleep quality on a multisystem biological risk index that is known to be associated with morbidity and...

  • Prostate Specific Membrane Antigen (PSMA) Regulates Angiogenesis Independently of VEGF during Ocular Neovascularization. Grant, Christina L.; Caromile, Leslie A.; Durrani, Khayyam; Rahman, M. Mamunur; Claffey, Kevin P.; Guo-Hua Fong; Shapiro, Linda H. // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    Background: Aberrant growth of blood vessels in the eye forms the basis of many incapacitating diseases and currently the majority of patients respond to anti-angiogenic therapies based on blocking the principal angiogenic growth factor, vascular endothelial growth factor (VEGF). While highly...

  • Effects of Statins on Nonlipid Serum Markers Associated with Cardiovascular Disease. Balk, Ethan M.; Lau, Joseph; Goudas, Leonidas C.; Jordan, Harmon S.; Kupelnick, Bruce; Kim, Linda U.; Karas, Richard H. // Annals of Internal Medicine;10/21/2003, Vol. 139 Issue 8, p670 

    Investigates the effects of statins on nonlipid serum markers associated with cardiovascular disease. Benefits of statin; Ability of statins to reduce risk for cardiovascular disease; Importance of nonlipid factors in the pathogenesis of atherosclerosis.

  • Fruit and vegetables and cardiovascular risk profile: a diet controlled intervention study. Broekmans, W.M.R.; Klopping-Ketelaars, W.A.A.; Kluft, C.; van den Berg, H.; Kok, F.J.; van den Poppel, G. // European Journal of Clinical Nutrition;Aug2001, Vol. 55 Issue 8, p636 

    Presents information on a study that examined the effects of fruit and vegetables consumption on markers of risk for cardiovascular disease. Methodology of the study; Results and discussion on the study.

  • Reference values for quantitative left ventricular and left atrial measurements in cardiac computed tomography. Stolzmann, Paul; Scheffel, Hans; Leschka, Sebastian; Schertler, Thomas; Frauenfelder, Thomas; Kaufmann, Philipp A.; Marincek, Borut; Alkadhi, Hatem // European Radiology;Aug2008, Vol. 18 Issue 8, p1625 

    To assess reference values for left ventricular (LV) and left atrial (LA) dimensions, global LV function, and LV-myocardial mass for cardiac CT. We examined 120 subjects undergoing a coronary angiography using 64-slice and dual-source CT. All individuals had a low cardiovascular risk, normal...

  • Computationally generated biomarkers predicted CV deaths.  // Cardiology Today;Nov2011, Vol. 14 Issue 11, p34 

    The article discusses research on the use of computationally generated biomarkers to predict cardiovascular-related deaths, by Z. Syed and colleagues, published in "Science Translational Medicine."

  • Holotranscobalamin and methylmalonic acid as prognostic markers following an acute myocardial infarction. Aarsetøy, H.; Valente, E.; Reine, A.; Mansoor, M. A.; Grundt, H.; Nilsen, D. W. T. // European Journal of Clinical Nutrition;Mar2008, Vol. 62 Issue 3, p411 

    Objective:To evaluate whether low levels of holotranscobalamin (holoTC) or elevated levels of methylmalonic acid (MMA), both indicators of vitamin B12 deficiency, might predispose to new cardiovascular events following an acute myocardial infarction (MI).Design:A prospective prognostic...

  • Cardiovascular Disease Risk Prediction Factors. Sniderman, Allan D.; Furberg, Curt D. // JAMA: Journal of the American Medical Association;11/21/2012, Vol. 308 Issue 19, p1969 

    A letter to the editor is presented in response to the article "Emerging Risk Factors Collaboration: Lipid-Related Markers and Cardiovascular Disease Prediction," by Emanuele Di Angelantonio, Pei Gao and L. Pennells in the previous issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics